{
  "id": 6799037,
  "title": "Pharming Gets FDA Approval For Joenja In Children With APDS",
  "url": "https://urgent.news/2026/09/11/pharming-gets-fda-approval-for-joenja-in-children-with-apds",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-11T20:54:17.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/pharming-gets-fda-approval-joenja-children-apds"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Pharming Group N.V. (PHARM.AS) said the U.S. Food and Drug Administration has approved Joenja (leniolisib) for children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome, or APDS, who weigh at least 27 kg.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}